Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1232 of 5804
-
New registry study tests antibody drugs for rare nerve disease
Disease control Recruiting nowThe primary objective of this registry study is to evaluate the therapeutic efficacy and safety profiles of distinct monoclonal antibody-based therapies for aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorders within the Chinese population under real-…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Promising combo targets tough esophageal cancer in small trial
Disease control Recruiting nowIn the era of immunotherapy, the standard second-line treatment regimen for locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) remains controversial. This prospective, single-center, single-arm phase II clinical study aims to evaluate the efficacy and safety of…
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple tourniquet stop deadly postpartum bleeding?
Disease control Recruiting nowThis multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies
Phase: NA • Sponsor: LLC UkrMedGroup • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a malaria drug boost leukemia treatment?
Disease control OngoingChronic myeloid leukaemia (CML) is a blood cancer with an annual worldwide incidence of 1/100,000 population. Imatinib is used for the treatment of CML and has significantly improved the management of the disease. However, the incidence of treatment failure due to imatinib resist…
Phase: PHASE2 • Sponsor: Obafemi Awolowo University • Aim: Disease control
Last updated Jun 26, 2026 14:03 UTC
-
New drug aims to reverse fatty liver damage in MASH patients
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical study evaluating the efficacy and safety of IBI362 in MASH subjects. Subjects will be randomly assigned to IBI362 low-dose, high-dose and placebo groups. The entire trial cycle includes a 8-week …
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can surgery or radiation boost lung cancer control after targeted therapy?
Disease control Recruiting nowThis is a single-arm, open-label, phase II study evaluating the clinical outcomes of local therapy (surgery or radiotherapy) to the primary tumor in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) who have achieved disease control following first-line treatm…
Phase: PHASE2 • Sponsor: Pusan National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Drug-Only approach may prevent Post-Procedure pancreatitis without stent risks
Prevention Recruiting nowPancreatitis is the most common and serious complication following post-endoscopic retrograde cholangiopancreatography (ERCP) and is associated with occasional mortality, extended hospital stays, and increased healthcare expenses. Rectal non-steroidal anti-inflammatory drugs (NSA…
Phase: NA • Sponsor: Air Force Military Medical University, China • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Could a common steroid save kids from septic shock?
Disease control CompletedAlthough, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contribut…
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Diabetes risk from statins in schizophrenia: could metformin be the answer?
Disease control Recruiting nowSchizophrenia is a severe mental illness associated with significant morbidity and disability. Patients often experience metabolic side effects from antipsychotic medications, including weight gain and dyslipidemia. Statins, commonly used to manage dyslipidemia, can lower cholest…
Phase: PHASE3 • Sponsor: Central South University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a headset and virtual therapy ease both pain and PTSD?
Symptom relief Recruiting nowThe purpose of this study is to examine comparative effectiveness of two home-based telemedicine delivered interventions: transcranial Direct Current Stimulation (tDCS) combined with Massed Prolonged Exposure (Massed-PE) vs. Sham tDCS combined with Massed PE, focusing on pain and…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Could a better stove save your lungs? major trial tests clean cooking
Prevention Recruiting nowThe goal of this clinical trial is to evaluate the independent and synergistic effects of liquefied petroleum gas (LPG) substitution and improved ventilation on household air pollution (HAP) reduction and cardiopulmonary health. The main questions it aims to answer are: 1. Does …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Could mild low-oxygen air boost nerve repair without surgery?
Disease control ENROLLING_BY_INVITATIONPeripheral nerve injuries are common and often associated with poor outcomes including incomplete repair, debilitating pain states and compromised function. Although nerve regeneration can be enhanced by brief electrical nerve stimulation at the time of or before surgical repair …
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New injection aims to melt dangerous neck plaques in High-Fat patients
Disease control ENROLLING_BY_INVITATIONThis is a researcher-initiated study to evaluate the effect of DR10624 injection on carotid atherosclerotic plaques in patients with hypertriglyceridemia and carotid atherosclerotic plaques. The study adopts a randomized, double-blind, placebo-controlled design. The treatment gro…
Phase: NA • Sponsor: Junbo Ge • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
AI boosts colonoscopy accuracy to prevent advanced polyps
Disease control Recruiting nowThe goal of this prospective study is to to evaluate the prevalence of metachronous advanced colonic lesions in subsequent surveillance colonoscopies in patients who had previously undergone AI-assisted colonoscopy to conventional colonoscopy examinations. The main question it a…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Shock therapy vs. ketamine: which works better for severe depression?
Symptom relief CompletedThis study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).
Phase: NA • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Blood tests could predict melanoma treatment success
Knowledge-focused Recruiting nowThis prospective, observational cohort study aims to explore the multi-omics profiles of liquid biopsies and develop clinical biomarkers in melanoma. Two hundred participants with pathologically confirmed acral or cutaneous melanoma who are scheduled to receive standard first-lin…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Blood tests may reveal earliest signs of Alzheimer's
Knowledge-focused Recruiting nowThis project aims to study on one hand the early mitochondrial alterations, common or specific, occurring in peripheral cells of patients with Alzheimer's disease or related dementia and, on the other hand, identify the metabolomic biomarkers that may be at the origin of mitochon…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Brain test could match PTSD veterans to the right medication
Knowledge-focused Recruiting nowA substantial majority of Veterans with posttraumatic stress disorder (PTSD) continue to suffer even with the best current medications. Progress in developing more effective medications is hampered by the substantial variability within Veterans with PTSD, meaning the most effecti…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a nighttime sound machine help fight Alzheimer's?
Symptom relief ENROLLING_BY_INVITATIONThis proof-of-concept study explores whether long-term home-based closed-loop auditory stimulation during sleep enhances slow-wave activity (SWA) and yields preliminary efficacy signals in patients with amnestic mild cognitive impairment due to Alzheimer's disease (MCI-AD), confi…
Phase: NA • Sponsor: Bitbrain • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a smartphone app help prevent sudden infant death?
Prevention Recruiting nowSudden Unexplained Infant Death (SUID) is the leading cause of death in infants age 28 days to 1 year. Protective factors, such as supine positioning, firm sleep surface, breastfeeding, pacifier use, elimination of soft objects from the sleep space, and avoidance of tobacco, alco…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC